Centerline Biomedical key facts
as of Oct 2026- Developer of three-dimensional visualization and real-time navigation system designed to improve endovascular procedures and reduce radiation exposure.
- Centerline Biomedical is valued at approximately $67.2M as of Oct 2026 (last reported valuation).
- It has raised $79.4M across 4 recorded rounds; the latest was Early Stage VC ($10.8M) in Apr 2025.
- Notable investors include MedTech Innovator, Jumpstart Ventures, JobsOhio Ventures, Gana Yantrika Enterprises, Cleveland Clinic — 15 tracked in total.
- Centerline Biomedical has filed 4 Form Ds with the SEC since 2023, most recently Apr 2025 ($10.8M sold to 8 investors).
- Status: Privately Held (backing).
Centerline Biomedical's last reported valuation, Jun 2022. Nothing priced has surfaced since.
- ·The complete investor list: 15 names
- ·Watch Centerline Biomedical: the Monday email on marks, rounds and moves
Centerline Biomedical funding rounds
4 roundsWho backs Centerline Biomedical
15+Centerline Biomedical valuation
Centerline Biomedical's last reported valuation was $67.2 million in Jun 2022. No priced round, secondary trade or fund mark has surfaced since.
How much has Centerline Biomedical raised?
Centerline Biomedical has raised $79.4 million across 4 recorded rounds since 2015. The largest was a $34.7 million early-stage round in Feb 2022; the most recent was a $10.8 million early-stage round in Apr 2025.
Centerline Biomedical has filed 4 Form Ds with the SEC since 2023, most recently in Apr 2025 ($10.8 million sold to 8 investors).
Centerline Biomedical investors
15 investors are on record for Centerline Biomedical, including MedTech Innovator, Jumpstart Ventures, JobsOhio Ventures and Gana Yantrika Enterprises. The early-stage round in Apr 2025 drew 8 investors.
About Centerline Biomedical
Developer of three-dimensional visualization and real-time navigation system designed to improve endovascular procedures and reduce radiation exposure. The company's navigation system is a non-x-ray-based multi-dimensional global positioning system that provides greater surgical precision and control, enabling physicians to perform optimal, radiation-free image-guided endovascular surgery.
- Sector
- Healthcare
- HQ
- Cleveland, OH, United States
- Founded
- 2014
- Employees
- 46
- Website
- centerlinebiomedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.